163 related articles for article (PubMed ID: 31416410)
21. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
van de Veen W; Wirz OF; Globinska A; Akdis M
Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
[TBL] [Abstract][Full Text] [Related]
22. Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children.
Pelaia C; Vatrella A; Lombardo N; Terracciano R; Navalesi P; Savino R; Pelaia G
Expert Opin Biol Ther; 2018 Feb; 18(2):197-204. PubMed ID: 29113525
[TBL] [Abstract][Full Text] [Related]
23. Novel immunotherapy vaccine development.
Jutel M; Akdis CA
Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):557-63. PubMed ID: 25304230
[TBL] [Abstract][Full Text] [Related]
24. Safety of engineered allergen-specific immunotherapy vaccines.
Focke-Tejkl M; Valenta R
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):555-63. PubMed ID: 22885888
[TBL] [Abstract][Full Text] [Related]
25. Allergen immunotherapy with cat allergen peptides.
Kay AB; Larché M
Springer Semin Immunopathol; 2004 Feb; 25(3-4):391-9. PubMed ID: 15007637
[TBL] [Abstract][Full Text] [Related]
26. Allergen immunotherapy in allergic rhinitis: current use and future trends.
Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
[TBL] [Abstract][Full Text] [Related]
27. Past, present, and future of allergen immunotherapy vaccines.
Dorofeeva Y; Shilovskiy I; Tulaeva I; Focke-Tejkl M; Flicker S; Kudlay D; Khaitov M; Karsonova A; Riabova K; Karaulov A; Khanferyan R; Pickl WF; Wekerle T; Valenta R
Allergy; 2021 Jan; 76(1):131-149. PubMed ID: 32249442
[TBL] [Abstract][Full Text] [Related]
28. Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy.
Nelson HS
Allergy Asthma Proc; 2020 Jan; 41(1):26-37. PubMed ID: 31888780
[No Abstract] [Full Text] [Related]
29. [New approaches for allergen-specific immunotherapy].
Cantillo JF; Puerta L
Biomedica; 2010; 30(3):440-53. PubMed ID: 21713346
[TBL] [Abstract][Full Text] [Related]
30. Peptide-based allergen specific immunotherapy for the treatment of allergic disorders.
El-Qutob D; Reche P; Subiza JL; Fernández-Caldas E
Recent Pat Inflamm Allergy Drug Discov; 2015; 9(1):16-22. PubMed ID: 25760734
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the use of nanoparticles for allergen-specific immunotherapy.
Pohlit H; Bellinghausen I; Frey H; Saloga J
Allergy; 2017 Oct; 72(10):1461-1474. PubMed ID: 28474379
[TBL] [Abstract][Full Text] [Related]
32. T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.
Wai CY; Leung NY; Leung PS; Chu KH
Clin Exp Allergy; 2016 Mar; 46(3):491-503. PubMed ID: 26610061
[TBL] [Abstract][Full Text] [Related]
33. New Treatments for Allergy: Advances in Peptide Immunotherapy.
Calzada D; Baos S; Cremades L; Cardaba B
Curr Med Chem; 2018; 25(19):2215-2232. PubMed ID: 29205109
[TBL] [Abstract][Full Text] [Related]
34. Allergen extracts for immunotherapy: to mix or not to mix?
Nony E; Martelet A; Jain K; Moingeon P
Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
[TBL] [Abstract][Full Text] [Related]
35. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Crameri R
Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
[TBL] [Abstract][Full Text] [Related]
36. Epitope peptides and immunotherapy.
Tanabe S
Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
[TBL] [Abstract][Full Text] [Related]
37. Allergen immunotherapy now and in the future.
Nelson HS
Allergy Asthma Proc; 2016 Jul; 37(4):268-72. PubMed ID: 27401313
[TBL] [Abstract][Full Text] [Related]
38. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.
Mueller RS; Jensen-Jarolim E; Roth-Walter F; Marti E; Janda J; Seida AA; DeBoer D
Allergy; 2018 Oct; 73(10):1989-1999. PubMed ID: 29675865
[TBL] [Abstract][Full Text] [Related]
39. New strategies for allergen immunotherapy.
Carnés J; Robinson DS
Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):92-101. PubMed ID: 19075996
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy.
Lee JH; Lee SH; Ban GY; Ye YM; Nahm DH; Park HS; Shin YS
Yonsei Med J; 2019 Jun; 60(6):570-577. PubMed ID: 31124341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
